Print Page | Contact Us | Sign In | Join
Corporate Supported Events

Come join us at our corporate events!  No pre-registration required.  Please see below for event schedule and details.

 Corporate Focus Group supported by MSD
Sunday September 7, 2014 6:40PM - 10:30PM
Room: Ocean 2
  MSD Company Description:click here  
  Title of Presentation:Immunotherapeutic Blockade of Melanoma Pembrolizumab; Implications for Nurses 
  Chair:Annie Young, RN, PhD
University of Warwick and University of Coventry and Warwickshire, Coventry, United Kingdom

    Corporate Lunch Symposium supported by MSD 
Monday September 8, 2014 12:00PM - 1:00PM
Room: Star Bay 1
 MSD Company Description:click here  
  Title of Presentation:Oncology Nurses - Emerging Roles and Responsibilities 2014 
  Chair:Rebecca Clark-Snow, RN, BSN, ONC 
  Speaker:Richard J. Gralla, MD, FACP 
  Learning Objectives:1. Inform the Oncology Nurse about the safety and efficacy of Aprepitant and Fosaprepitant for approrpriate patients is essential to optimal patient care
2. Discuss the multi-disciplinary approach to managing the cancer patient is critical and the education of the Oncology Nurse is an essential in this communication process
3. Oncology Nurses play an increasing role in patient care and medication management; this program will provide up to date clinical treatment guidelines critical to the oncology nurse
 Corporate Focus Group supported by Amgen
Monday September 8, 2014 5:30PM - 7:30PM
Room: Ocean 2
 Amgen Company Description: click here 
 Title of Presentation:New Treatment in Myeloma 
 Corporate Workshop Session supported by Amgen 
Tuesday September 9, 2014 9:00AM - 10:20AM
Room: Star Bay 1
 Amgen Company Description:click here 
 Title of Presentation:Managing Treatment Barriers in Patients Receiving Cancer Therapy 
David C. Dale, MD
University of Washington, 
Seattle, WA, United States

   Kathryn Ciccolini, RN, BSN, OCN
Memorial Sloan Kettering Cancer Center
New York, NY, United States

   Learning Objectives:1. Discuss different aspects of main oncology therapies adverse events, i.e. Myelotoxicity and Febrile Neutropenia, Tumor Lysis Syndrome, Infusion Reactions and EFGR Inhibitor Skin Reactions
2. Discuss management of those oncology therapies complications, in terms of prophylaxis and treatment approaches, based on guidelines and clinical trials
 Corporate Lunch Tutorial Session supported by Boehringer Ingelheim
Tuesday September 9, 2014 12:20PM - 1:20PM
Room: Star Bay 1
  Title of Presentation:Ideal Patient Management during EGFR Inhibitor Treatment 
  Speakers:  Carlos Jose Zuloaga Fernandez Del Valle
National Cancer Institute, Mexico,
ONKOS Clinical Care Guadalajara, Jalisco
  Learning Objectives:1. To identify the main AEs of EGFR Inhibitor treatment
2. To learn how to prevent and manage the main AEs with this treatment
3. To develop strategies of patient education on AEs management

 Corporate Lunch Tutorial Session supported by ICU Medical
Tuesday September 9, 2014 12:20PM - 1:20PM
Room: Star Bay 2
 ICU Medical Company Description:click here 
 Title of Presentation:Closed System Transfer Devices: Looking Beyond the Surface 
 Speaker:Marlon Garzo Saria, PhD(c), RN, AONCNS
University of California San Diego, San Diego, United States
 Learning Objectives:1. Describe current best practices to reduce occupational risk from hazardous drugs
2. Describe the role of CSTDs in reducing hazardous drug exposure risk
3. Discuss the characteristics of efficient CSTDs


 Corporate Lunch Tutorial Session supported by Novartis
Wednesday September 10, 2014 12:20PM - 1:20PM
Room: Star Bay 1
 Novartis Oncology Description:click here 
 Title of Presentation:Setting the Course for Optimal Adherence to Oral Therapies 
  Speakers:Kevin A. Schreffler, MSN, RN, OCN
Atlanta Cancer Care, Northside Cancer Institute, Atlanta, United States
   Marise Dutra Souto, RN, PhD
Breast Hospital / National Cancer Institute Brazil, Rio De Janeiro, Brazil
  Learning Objectives:1. Demonstrate increased knowledge and application of patient safety concepts for adherence to oral therapies in practice settings
2. Navigate the cancer patient safety framework online learning modules
3. Explore the various materials, offered through ISNCC in different languages, for patient education and nursing knowledge

 Corporate Lunch Tutorial Session supported by Paxman Coolers
Wednesday September 10, 2014 12:20PM - 1:20PM
Room: Star Bay 2
 Paxman Coolers Company Description:click here 
 Title of Presentation:Chemotherapy Induced Alopecia Matters – Let’s Prevent it!
 Chair:Jan Ouwerkerk, CNS, RN
Leiden University Medical Center, Leiden, The Netherlands
 Speakers:Annie Young, RN, PhD
University of Warwick and University of Coventry and Warwickshire, Coventry, United Kingdom
Corina van den Hurk, PhD
Comprehensive Cancer Centre, Eindhoven, The Netherlands

 Learning Objectives:1. To understand current literature on the importance of alopecia to our patients
2. To explore prevention of alopecia by scalp cooling
3. To look at current research areas of prevention